Alura Pharmaceuticals recently received its SAHPRA certification to import and distribute scheduled APIs to the manufacturing and compounding industries in South Africa. This certification confirms Alura Pharma as a sourcing specialist and distributor of APIs to the broader South African market.

An API (Active Pharmaceutical Ingredient), sometimes referred to as an AI (Active Ingredient), is the component in a pharmaceutical drug that is biologically active. This ingredient provides a direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or affects the structure or function of the body in humans or animals.

By securing this exclusive licence from SAHPRA, clients can rest assured that Alura Pharma complies with the stringent Good Distribution Practice (GDP) guidelines as prescribed by SAHPRA.

​

One of Alura Pharma’s key differentiators is its strong focus on understanding and fulfilling the precise needs of its customers. We aim to provide our clients with a professional approach to the import and supply of a broad spectrum of APIs, whether for bulk orders or specialised niche quantities for unique applications.

We pride ourselves on the following key elements of our service to clients:

• Adherence to all legal guidelines, laws, and notices issued by SAHPRA, SAPC, and the Department of Health, as well as Act 101 and the POPI Act.

• Open and honest business practices with both suppliers and clients.
• Fast and effective solutions, support, and guidance for clients.
• Transparent communication with a focus on understanding and addressing client needs.
• Cost-effective and cost-saving services for our clients.

Let our local qualified personnel and international network of pharmacists, scientists, and procurement officers assist you with your requirements.

​

Contact details:
Call us on 0861 666 778 or email us at:
RP@alurapharma.co.za
pieter@alurapharma.co.za
info@alurapharma.co.za